Current Edition


Biohaven points up Nurtec dual-migraine approval with growing stable of celebrity users

Biohaven Pharmaceuticals is flexing its migraine share leapfrog over powerhouse AbbVie—thanks to Nurtec ODT’s dual acute-plus-prevention nod and an aggressive digital-first strategy. Digital ads across …

Continue Reading →
Bristol Myers Squibb

Ogilvy Health’s new PR practice chief talks pharma image and social trends

There’s a shifting focus in pharma public relations from image to impact, says Ogilvy Health’s new PR practice president. Shannon Walsh, recently tapped to lead …

Continue Reading →